Therapeutics

Encapsula powder for precision drug delivery.

  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button
  • Slide title

    Write your caption here
    Button

Encapsula™

Encapsula™ utilizes self-assembling hyaluronic acid to encapsulate active ingredients within a porous hydrogel, enhancing the efficacy of existing skin boosters.
Features
• Hyaluronic Acid in a Porous Structure • Active Ingredient Encapsulation • Enhanced Durability
• Focused Targeting • Easy Application • Improved Moisturization

Dermatology

Skin Indications Eczema | Psoriasis

The porous hydrogel forms a layer on the skin’s surface, aiding in the better absorption of active ingredients into the skin.

Topical application

The hydrogel layer on the skin retains moisture by slowing evaporation, significantly improving hydration over time.

Oncology

Solid Tumour Indications

Neurology

Age Related Disorders

Our technology can deliver a variety of active pharmaceutical ingredients (APIs) with controlled release and long-lasting effect

Injectable DDS

Therapeutic Areas

- Oncology

- Neurology

- Cardiovascular

- Obesity

- Immunology

- Ophthalmology

- Orthopaedics


The drug loaded porous hydrogel matrix can be injected into various body sites, including:

  • Intradermal (into the skin)
  • Tissues
  • Organs
  • Intra-articular joints (within joints)
  • Tumours

Our products, developed through rigorous scientific research, demonstrates significant potential in two primary applications:


1. Advanced topical formulations for dermatological and cosmeceutical applications, facilitating targeted delivery with sustained therapeutic efficacy


2. Novel injectable drug delivery platforms enabling optimized pharmacokinetics for diverse therapeutic indications across multiple disease states